Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT01980875 · TERMINATED
Trial details
- NCT number
- NCT01980875
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-21
- Primary completion
- 2016-05-13
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.